Plug Occlusion of Anal Fistula Shows Mixed Results
|
By HospiMedica International staff writers Posted on 16 Feb 2014 |
|
Image: The Biodesign anal fistula plug being drawn through the fistula (Photo courtesy Cook Medical).
A new study reveals that using a collagen anal fistula plug as a means of obliterating the fistula tract and promoting healing has unexplained variations.
Researchers at the Karolinska Institutet (KI; Stockholm, Sweden), Danderyd Hospital (Stockholm, Sweden), and other institutions conducted a retrospective multicenter study involving 126 patients (mean age 47 years) in four Stockholm hospitals who underwent an anal plug fistula procedure between June 2006 and June 2010. Of these patients, 85% were cryptoglandular, 64% were male, and had a mean 2.9 previous fistula procedures. The outcome after first plug insertion was assessed by chart review performed at a minimum of eight months after insertion, and hazard models were used to assess associations of various factors with fistula healing.
The results showed that after a median time of 13 months, 30 (24%) fistulae were closed without discomfort or secretion; the outcome in the four hospitals varied between 13% and 33% for a similar numbers of patients. Patients with an anterior fistula experienced a success rate of 12% compared with 32% of those with posterior tracks, and 41% of those with a lateral internal opening. Age, sex, and number of previous procedures were not associated with healing. The study was published on February 11, 2014, in Colorectal Disease.
“The Biodesign anal fistula plug was introduced as a means of obliterating the fistula tract and promote healing through biocompatibility,” concluded lead author Johannes Blom, MD, PhD, of the KI Center of Surgical Gastroenterology, and colleagues. “The results demonstrated unexplained variations from good to bad; anterior fistulae were much less likely to heal than fistulae in other locations.”
The Biodesign anal fistula plug used in the study acts as a scaffold, allowing tissue to grow and close the fistula tract. The result is remodeled, vascularized tissue and fistula closure without the muscle damage from surgery that can lead to incontinence. The plug is designed to keep the sphincter intact and restores natural form and function with minimal scar tissue formation. The Biodesign anal fistula plug is a product of Cook Medical (Bloomington, IN, USA), and is available with or without retention button.
Related Links:
Karolinska Institutet
Danderyd Hospital
Cook Medical
Researchers at the Karolinska Institutet (KI; Stockholm, Sweden), Danderyd Hospital (Stockholm, Sweden), and other institutions conducted a retrospective multicenter study involving 126 patients (mean age 47 years) in four Stockholm hospitals who underwent an anal plug fistula procedure between June 2006 and June 2010. Of these patients, 85% were cryptoglandular, 64% were male, and had a mean 2.9 previous fistula procedures. The outcome after first plug insertion was assessed by chart review performed at a minimum of eight months after insertion, and hazard models were used to assess associations of various factors with fistula healing.
The results showed that after a median time of 13 months, 30 (24%) fistulae were closed without discomfort or secretion; the outcome in the four hospitals varied between 13% and 33% for a similar numbers of patients. Patients with an anterior fistula experienced a success rate of 12% compared with 32% of those with posterior tracks, and 41% of those with a lateral internal opening. Age, sex, and number of previous procedures were not associated with healing. The study was published on February 11, 2014, in Colorectal Disease.
“The Biodesign anal fistula plug was introduced as a means of obliterating the fistula tract and promote healing through biocompatibility,” concluded lead author Johannes Blom, MD, PhD, of the KI Center of Surgical Gastroenterology, and colleagues. “The results demonstrated unexplained variations from good to bad; anterior fistulae were much less likely to heal than fistulae in other locations.”
The Biodesign anal fistula plug used in the study acts as a scaffold, allowing tissue to grow and close the fistula tract. The result is remodeled, vascularized tissue and fistula closure without the muscle damage from surgery that can lead to incontinence. The plug is designed to keep the sphincter intact and restores natural form and function with minimal scar tissue formation. The Biodesign anal fistula plug is a product of Cook Medical (Bloomington, IN, USA), and is available with or without retention button.
Related Links:
Karolinska Institutet
Danderyd Hospital
Cook Medical
Gold Member
CPAP Ventilator
Somnus DM18
Adjustable Mobile Barrier
M-458
Open Stapler
PROXIMATE Linear Cutter
Latest Surgical Techniques News
- Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
Channels
Critical Care
view channel
Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
Skin cancer remains one of the most dangerous and common cancers worldwide, with early detection crucial for improving survival rates. Traditional diagnostic methods—visual inspections, imaging, and biopsies—can... Read more
Pulse Oximeter Index Offers Non-Invasive Guides for Fluid Therapy
In patients with acute circulatory failure, deciding whether to administer intravenous fluids is often a life-or-death decision. Too little fluid can leave organs underperfused, while too much can cause... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more